BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
Published in April 2008.
The link address is: http://rheumatology.oxfordjournals.org/cgi/data/kel216a/DC1/1
BSR Guidelines for Monitoring Second Line Drugs